Abstract
Dr. Gladstein is Associate Professor of Pediatrics and Neurology, University of Maryland School of Medicine, and Director, Pediatric Headache Clinic and Pediatric Hospitalist Program, University of Maryland Medical Center, 22 S. Greene Street, Baltimore, MD 21201; E-mail: [email protected]. The author has disclosed that he is/was a member of the speakers bureaus of GlaxoSmithKline and Pfizer, Inc. The author also has disclosed that the use of triptans in the treatment of pediatric migraine as discussed in this article has not been approved by the U.S. Food and Drug Adminisration. Lippincott CME Institute, Inc., has identified and resolved all faculty conflicts of interest regarding this educational activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
